Anti-infection
Achievements
Integrating resources and leading the industry
  • The first product introduced to China
    The first product introduced to China
    1998
  • Core products
    Core products
    1
  • Chinese patients benefited nearly
    Chinese patients benefited nearly
    3
    million +
  • Experts invited to industry conferences
    Experts invited to industry conferences
    400
*Data from 2021
Anti-infection
Development history

In 1999, Mepem® was introduced in China and has been used for more than 20 years. For the past 20 years, we have been adhering to the constant belief in our hearts: upholding the "patient-centered" approach and striving to "become a high-quality enterprise that contributes continuously to the development of China's medical industry". In the future, we will continue to contribute to the development of therapeutics for severe infections, save more lives, and achieve more happiness among patients.

2018
Undertook a 24-city lecture tour on Chinese Guidelines for the Diagnosis and Treatment of Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Adults.
2017
Restored the drug indication of abdominal infection.
2004
Entered the National Reimbursement Drug List
1999
On 20 May, the meeting on the listing of Mepem® was held in Beijing.
1998
Mepem® was launched in China and approved for treating sepsis, pneumonia, peritonitis, osteomyelitis, and other infections.
1996
The former national health department approved the clinical study of Mepem® for marketing in China.
Anti-infection
Integrating resources and leading the industry
Anti-infection
Promotional video

Based on the 20-year history of Mepem®, the video displays its vigorous development over the past 20 years in the form of sand paintings. Mepem® works together with doctors to save more patients with severe infections.

×
Copyright @2024 住友制药. All rights reserved  (沪)  -非经营性-2016-2024  沪ICP备16016494号-3   沪公网安备 31010102002939号
You are leaving the official website of
Sumitomo Pharma (Suzhou) Co., Ltd.

You are about to leave the official website of Sumitomo Pharma (Suzhou) Co., Ltd. and be redirected to a third-party website. Please be aware of the risks involved.